Name | 4-{[({[(2R)-4-(3,4-Dichlorobenzyl)-2-morpholinyl]methyl}carbamoyl)amino]methyl}benzamide |
---|---|
Synonyms |
4-{[({[(2R)-4-(3,4-Dichlorobenzyl)-2-morpholinyl]methyl}carbamoyl)amino]methyl}benzamide
Benzamide, 4-[[[[[[(2R)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl]methyl]amino]carbonyl]amino]methyl]- |
Description | GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays; reverses CCL11-induced activation of CDK5 at 10 uM in rat neurons expressed CCR3, blocks CCL11-induced the production of Aβ and dendritic spine loss in the hippocampal neuronal cultures. |
---|---|
References | References 1. Neighbour H, et al. Clin Exp Allergy. 2014 Apr;44(4):508-16. View Related Products by Target Chemokine Receptor (CCR and CXCR) |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 685.8±55.0 °C at 760 mmHg |
Molecular Formula | C21H24Cl2N4O3 |
Molecular Weight | 451.346 |
Flash Point | 368.5±31.5 °C |
Exact Mass | 450.122559 |
LogP | 1.50 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.608 |